TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc. Information

Contact top employees from TransCode Therapeutics, Inc.

Summary

TransCode Therapeutics, Inc. is a public company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by Michael Dudley. Its headquarters is located at Boston, Massachusetts, USA. The estimated number of employees - 6. The TransCode Therapeutics, Inc. annual revenue is estimated at < 1M. Total funding of the company - $25M. To connect with TransCode Therapeutics, Inc. employee register on SignalHire.

Organization Website

transcodetherapeutics.com

Social Links

linkedIn

Phone Number

857-301-6857

Industries

Headquarters Location

73b Chapel St, Newton, Massachusetts, 02458 US

Employees Size

10-50 employees

Specialties

Oncology, RNA, Diagnostics, Nucleic Acid Therapeutics, Orphan Disease Designation, Metastasis, Checkpoint Inhibitor, Pattern Recognition Receptor, mRNA vaccine, CRISPR

SIC Code

2836

DMA Code

Greater Boston

Founded

2016

Operating Status

Independent Company

Estimated Website Traffic

The chart shows a growth in traffic to the transcodetherapeutics.com website. In November, traffic increased to 2653, compared to 2651 in the previous month. The highest traffic in 2025 was recorded in November, reaching 2653 visits.

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at TransCode Therapeutics, Inc. shows a diverse range of experience levels:
20% have been with the company for less than 1 year10% for 1–2 years20% for 3–4 years30% for 5–7 years20% for 8–10 years
Ex-employees positions
In Company
In New Company
Contact top employees from TransCode Therapeutics, Inc.
Sue Duggan
Senior Vice President, Operations
View
Philippe Calais
CEO & Chairman, Transcode Therapeutics (NASDAQ: RNAZ)
View
Qiyong Liu
Vice President of Research & Development, Chief Scientist
View
Joann Brown
Staff Accountant
View
Lisa Fortin
Director Clinical Operations
View
Elizabeth Adkins Czerepak
Chairman of Audit Committee, Board of Directors
View
Tom Fitzgerald
Chief Financial Officer; Director
View
Md Jaman
Senior Accountant
View
Zdravka Medarova
Chief Technology Officer
View
Tania Montgomery
Director of Business Development/ Strategic Marketing
View
Nicholas Rossettos
Interim Chief Financial Officer Advisor
View
Neil Robertson
Principal Scientist
View

FAQ

TransCode Therapeutics, Inc. operates in the Biotech industries. More details can be found on the official website: transcodetherapeutics.com.
The headquarters of TransCode Therapeutics, Inc. are located in Newton, United States.
The current CEO of TransCode Therapeutics, Inc. is Michael Dudley
You can contact TransCode Therapeutics, Inc. by phone at 857-301-6857.
TransCode Therapeutics, Inc. currently employs 10-50 people.
TransCode Therapeutics, Inc.'s revenue is approximately < 1M.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP